SUMO3 and breast carcinoma: Furthermore, HIDEEP reveals that doxorubicin directly targets TOP2A, one of breast cancer-causing genes, and dexamethasone has impacts on TOP2A through HEPs such as ANXA1 → SUMO3 → TOP2A and NR0B1 → UBC → TOP2A (Fig. 4d).